These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32929931)

  • 1. [Complex treatment of a patient with neurofibromatosis type 2].
    Rynda AY; Olyushin VE; Rostovtsev DM; Zabrodskaya YM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):98-104. PubMed ID: 32929931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cranial nerve schwannomas and meningiomas as a hallmark sign of neurofibromatosis type 2 in a child.
    Halefoğlu AM
    Turk J Pediatr; 2018; 60(1):107-110. PubMed ID: 30102490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of multiple tumors in neurofibromatosis type 2 patients.
    Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
    Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
    Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
    Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the
    Basenach E; Förster A; Raab P; Alzein S; Schmidt G; Krauss JK; Schlegelberger B; Heidenreich F; Auber B; Hartmann C; Wiese B; Weber RG
    Clin Neuropathol; 2022; 41(4):162-167. PubMed ID: 35445657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2.
    Lawson McLean AC; Rosahl SK
    World Neurosurg; 2017 Feb; 98():152-161. PubMed ID: 27777160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual case of multiple cellular and malignant schwannomas of the cranial and spinal nerves.
    Suresh TN; Mahadevan A; Chandrashekhar Sagar B; Santosh V; Yasha TC; Shankar SK
    Clin Neuropathol; 2003; 22(1):23-9. PubMed ID: 12617190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2.
    Cunliffe IA; Moffat DA; Hardy DG; Moore AT
    Br J Ophthalmol; 1992 May; 76(5):310-2. PubMed ID: 1390517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contiguous conventional and plexiform schwannomas. Report of two cases.
    White JB; Scheithauer BW; Amrami KK; Babovic-Vuksanovic D; Spinner RJ
    J Neurosurg; 2006 Feb; 104(2):319-24. PubMed ID: 16509508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic image (252). A woman with complaints of tinnitus, hearing loss and headache].
    te Lintelo MP; Koehler PJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2565. PubMed ID: 16320667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
    Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
    Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral acoustic neurinomas with multiple meningiomas.
    ROVINE BW; MULFORD EH
    Neurology; 1960 Mar; 10():323-4. PubMed ID: 14439650
    [No Abstract]   [Full Text] [Related]  

  • 18. A Diagnostic Dilemma: Multiple Primary Intracranial Tumors Without Vestibular Schwannomas.
    Faucett EA; Larsen BT; Khan R; Chiu AG; Chang EH
    Ann Otol Rhinol Laryngol; 2016 Nov; 125(11):938-942. PubMed ID: 27553596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Neuro-Ophthalmologists in the Care of Patients With Neurofibromatosis Type 2.
    Landau K
    J Neuroophthalmol; 2020 Sep; 40 Suppl 1():S51-S56. PubMed ID: 32796346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series.
    Alanin MC; Klausen C; Caye-Thomasen P; Thomsen C; Fugleholm K; Poulsgaard L; Lassen U; Mau-Sorensen M; Hofland KF
    Int J Neurosci; 2016 Nov; 126(11):1002-6. PubMed ID: 26365467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.